Tuesday, May 15, 2018Metawave Snags $10M For Automotive RadarMetawave Corporation, a developer of automotive radar technology with has an office in Carlsbad, has raised $10M in a funding round, the company announced on Tuesday morning. The funding was led by DENSO, and also included Toyota AI Ventures, Hyundai Motor Company and Asahi Glass plus existing investors Motus Ventures, Khosla Ventures, Autotech Ventures, Bold Capital, SAIC Capital, Western Technology Investment (WTI), and Alrai Capital. Metawave said it is developing "smart" automotive radar sys (More info...)
posted on Tuesday, May 15, 2018 (More)(Full story)
Rael Raises $2.1M For Feminine Products From Thrive Market VenturesBuena Park-based Rael, a developer of feminine hygiene products, has raised $2.1M in a "pre-series A" funding, the company disclosed on Tuesday. The funding came from SoftBank Ventures Korea and Thrive Market Ventures. Thrive Market Ventures is the venture capital investment arm of Los Angeles-based organic grocery and products company Thrive Market, which has recently been making investments in companies related to its organic food and products. Thrive made its very first investment in March, (More info...)
posted on Tuesday, May 15, 2018(Full story)
Tinder Settles With Chinese Dating App Developer TantanLos Angeles-based dating app developer Tinder, which is owned by Match Group, has settled a patent and trademark infringement lawsuit with Chinese dating app developer Tantan. Tinder had accused Tantan of creating a copycat of Tinder's system in China. Financial details of that settlement were not announced. Match Group had filed its patent and trademark infringement lawsuit against Tantan--often referrred to as "China's Tinder"--back in March. The patent lawsuit, Match Group LLV v. Tantan Ltd., (More info...)
posted on Tuesday, May 15, 2018(Full story)
Alteryx Seeks $200M In Debt FinancingIrvine-based Alteryx, the publicly held developer of data visualization and analytics software, said late Monday that it is seeking to offer $200M in convertible senior notes, which it says it will use for general corporate purposes, acquisition, and other "strategic transactions". Alteryx did not detail any other specifics of what it would use the new funding for. Alteryx, which had its IPO in 2017, already has acquired at least two other companies, including data science company Yhat back in 2 (More info...)
posted on Tuesday, May 15, 2018(Full story)
Ansun Biopharma Raises $85MSan Diego-based Ansun BioPharma, a biopharmaceuticals company which is focused on anti-virals for treating severe, viral respiratory tract infections, has raised $85M in a Series A funding. The funding was led by Sinopharm Healthcare Fund and Lilly Asia Ventures, and also included Lyfe Capital, Yuanming Capital, Matrix Partners China, 3e Bioventures Capital, Oceanpine Capital, VI Ventures, and Joincap Investment. As part of the funding, Sinopharm Capital's Dr. Xiaoming Yang, and Lilly Asia Ventu (More info...)
posted on Tuesday, May 15, 2018 (More)(Full story)
Good Eggs Eyes Southern California Expansion Next Year, After $50M FundingSan Francisco-based Good Eggs, a fresh meal kit and grocery delivery startup, said today that it is aiming at expansion in Southern California next year, after raising $50M in a new funding round. The funding was led by Benchmark Capital, and also included Index Ventures, Obvious Ventures, S2G Ventures, DNS Capital, Uprising and Collaborative Fund. The company did not give an exact date it hopes to launch in the region, and also did not detail exactly which areas its service would be available f (More info...)
posted on Tuesday, May 15, 2018 (More)(Full story)
TherOx Finds Debt FundingIrvine-based medical device company TherOx, which is developing medical devices to treat acute myocardial infarction (AMI), recently announced it has received a debt financing. The financing came from its existing investors, ZOLL Medical Corporation, which is owned by Asahi Kasei Group. According to ThereOx, the proceeds of the funding will go towards the U.S. market introduction and commercialization of its SuperSaturated Oxygen (SSO2) Therapy system upon receipt of Food and Drug Administration (More info...)
posted on Tuesday, May 15, 2018(Full story)